V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015442 | 160020317 | 1.65 | 74.5 | null | 2020-04-17 | 2020-04-22 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 100059880 |
| 160015449 | 160020318 | 1.77 | 66.5 | Palliative (P) | null | null | NIVOLUMAB | 02 | N | NIVOLUMAB | 101614057 |
| 160015470 | 160020319 | 1.76 | 72 | Palliative (P) | 2017-06-01 | 2017-06-08 | Trabectedin | 02 | null | TRABECTEDIN | 100866674 |
| 160015528 | 160020320 | 1.88 | 106.8 | Palliative (P) | 2017-02-17 | 2017-02-19 | DOXORUBICIN | N | N | VINORELBINE | 101653921 |
| 160015535 | 160020321 | 1.79 | 63.9 | Palliative (P) | 2020-03-28 | 2020-04-25 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101424685 |
| 160015570 | 160020322 | 1.6 | 66.55 | Palliative (P) | 2020-12-27 | 2020-12-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100897573 |
| 160015595 | 160020323 | 1.86 | 61.8 | null | null | 2018-06-20 | Trabectedin | N | null | TRABECTEDIN | 100668641 |
| 160015679 | 160020324 | 1.6 | 91 | Palliative (P) | 2019-08-27 | 2019-09-05 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100494943 |
| 160015739 | 160020325 | 1.65 | 97.2 | Neo-adjuvant (N) | 2020-01-01 | 2020-04-03 | Bevacizumab | 02 | N | BEVACIZUMAB | 100125940 |
| 160015750 | 160020326 | 1.51 | 87 | Palliative (P) | 2018-10-13 | 2018-10-24 | Bevacizumab 15mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101263802 |
| 160015775 | 160020327 | 1.5 | 79 | Palliative (P) | 2018-05-20 | 2021-07-22 | Bevacizumab 15mg/kg | 02 | null | LIPOSOMAL DOXORUBICIN | 101406357 |
| 160015807 | 160020328 | 1.71 | 84.95 | Palliative (P) | 2021-03-18 | 2021-03-25 | Bevacizumab 15mg/kg | null | N | BEVACIZUMAB | 100864853 |
| 160015809 | 160020329 | 1.83 | 88.1 | Adjuvant (A) | 2022-04-01 | 2022-04-16 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100276551 |
| 160015890 | 160020331 | 1.81 | 81.8 | Neo-adjuvant (N) | 2019-03-10 | 2019-03-28 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100523382 |
| 160015916 | 160020333 | 1.64 | 58 | Neo-adjuvant (N) | 2017-09-27 | 2017-10-04 | Bevacizumab | 02 | null | BEVACIZUMAB | 101853045 |
| 160015952 | 160020334 | 1.5 | 88.6 | Palliative (P) | 2020-03-08 | 2020-03-19 | Bevacizumab 7.5mg/kg | 02 | N | DOCETAXEL + GEMCITABINE | 100137761 |
| 160015969 | 160020335 | null | 58.2 | Palliative (P) | 2018-10-27 | 2018-11-05 | Bevacizumab 7.5mg/kg | 02 | null | DOCETAXEL + GEMCITABINE | 101127652 |
| 160015971 | 160020336 | 1.63 | 80.2 | Palliative (P) | 2018-11-18 | 2018-11-25 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101396540 |
| 160016038 | 160020337 | 1.53 | 116 | Palliative (P) | 2019-10-24 | 2019-11-13 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101849043 |
| 160016071 | 160020338 | 1.53 | 61 | null | 2020-01-09 | 2020-01-11 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101610285 |
| 160016215 | 160020339 | 1.68 | 47.5 | null | 2018-09-23 | 2018-09-26 | Bevacizumab 7.5mg/kg | 02 | null | CARBOPLATIN + GEMCITABINE | 101711099 |
| 160016287 | 160020340 | 1.54 | 85.1 | Palliative (P) | 2018-09-18 | 2018-10-05 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101210219 |
| 160016304 | 160020341 | 1.83 | null | Palliative (P) | 2018-01-23 | 2019-04-11 | Bevacizumab | null | null | CARBOPLATIN + PACLITAXEL | 100017071 |
| 160016323 | 160020342 | 1.92 | 69 | Palliative (P) | 2020-05-10 | 2021-09-14 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101402071 |
| 160016348 | 160020343 | 1.52 | 59.4 | Palliative (P) | 2017-08-24 | 2018-04-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100954658 |
| 160016429 | 160020344 | 1.75 | 70 | null | 2017-09-03 | 2017-09-17 | Bevacizumab 7.5mg/kg | 02 | null | PACLITAXEL | 100736808 |
| 160016440 | 160020345 | 1.54 | 67.2 | Adjuvant (A) | 2019-03-18 | 2019-04-30 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + GEMCITABINE | 100907107 |
| 160016447 | 160020346 | 1.7 | 49.2 | Palliative (P) | 2021-04-09 | 2021-04-17 | Bevacizumab | 02 | N | DOCETAXEL + GEMCITABINE | 101003237 |
| 160016479 | 160020347 | 1.76 | 123.4 | null | 2019-08-06 | 2019-08-11 | GemCarbo Days 1+8 | 2 | N | CARBOPLATIN + GEMCITABINE | 100294636 |
| 160016488 | 160020348 | 1.51 | 89.65 | Palliative (P) | 2018-08-13 | 2018-08-15 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100949605 |
| 160016540 | 160020349 | 1.75 | 67.5 | Adjuvant (A) | 2022-01-30 | 2022-02-08 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + PACLITAXEL | 101003034 |
| 160016547 | 160020350 | 1.5 | 73 | Palliative (P) | 2019-12-30 | 2020-01-23 | Bevacizumab | 02 | N | CISPLATIN + PEMETREXED | 100387025 |
| 160016613 | 160020351 | 1.65 | 63.5 | Palliative (P) | 2017-08-11 | 2017-08-29 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101487963 |
| 160016636 | 160020352 | 1.54 | 84.9 | Palliative (P) | 2021-06-30 | 2021-07-12 | DOCETAXEL + GEMCITABINE | N | N | DOCETAXEL + GEMCITABINE | 100921383 |
| 160016640 | 160020353 | 1.67 | 74.9 | Palliative (P) | 2020-07-12 | 2020-09-05 | Bevacizumab 7.5mg/kg | 02 | N | PACLITAXEL | 100225927 |
| 160016710 | 160020354 | 1.77 | 67.7 | Palliative (P) | 2017-03-19 | 2017-03-26 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | EW EUROEWING 2012 ARM B IE | 100954690 |
| 160016749 | 160020355 | 0.98 | 70 | Palliative (P) | 2019-09-02 | 2019-09-16 | NB HRNBL-1 COJEC Ind COURSE C | 02 | N | NEMO TRIAL | 100080250 |
| 160016779 | 160020356 | 1.79 | 85.2 | Palliative (P) | 2021-11-20 | 2021-11-21 | LENVATINIB | 02 | N | STS RHABDO VIT0910 VINC IRINO TEMOZ | 100909788 |
| 160016811 | 160020358 | 1.85 | 70.8 | Curative (C) | null | null | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE | 100428216 |
| 160016844 | 160020359 | 1.54 | 78.2 | null | 2017-07-08 | 2017-07-24 | CISPLATIN + ETOPOSIDE | null | null | VINCRISTINE | 100517306 |
| 160016868 | 160020360 | 0 | 42.5 | Curative (C) | 2020-12-03 | 2021-01-20 | Doxorubicin + Ifosfamide | 02 | N | IVA | 101197738 |
| 160016885 | 160020361 | 1.61 | 93.7 | null | 2020-11-21 | 2020-12-09 | Trial Unspecified | 02 | N | VAI | 101028116 |
| 160016921 | 160020362 | 0 | 109 | Palliative (P) | 2022-02-19 | 2022-04-12 | Trial Unspecified | Y | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100601969 |
| 160016955 | 160020363 | 0 | 83.6 | Curative (C) | 2019-06-07 | 2019-07-08 | EW EuroEwing 2012 Arm B VC | 02 | N | NOT MATCHED | 101863220 |
| 160016959 | 160020364 | 0 | 82 | Palliative (P) | 2022-01-02 | 2022-01-30 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100659204 |
| 160016975 | 160020365 | 1.67 | 85.4 | Palliative (P) | 2019-07-12 | 2019-12-28 | Abiraterone | 02 | N | GEMCITABINE | 100761456 |
| 160016986 | 160020366 | 1.5 | 61 | Curative (C) | 2019-01-08 | 2019-04-05 | CAPECITABINE + OXALIPLATIN | Y | N | CREATE TRIAL | 100200365 |
| 160016990 | 160020367 | 1.8 | 36.8 | null | 2022-02-27 | 2022-03-01 | IVA | 02 | null | EW EUROEWING 2012 ARM A/B ZOL ACID | 101822042 |
| 160016993 | 160020368 | 1.79 | 88.2 | Curative (C) | 2021-01-11 | 2021-01-25 | NEMO TRIAL | 02 | null | IRINOTECAN + TEMOZOLOMIDE | 100212183 |
| 160017052 | 160020370 | 1.68 | 91.7 | Palliative (P) | 2020-11-26 | 2021-11-15 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100940818 |